Intuitive Surgical, Inc. vs Marqeta Inc — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Marqeta Inc trades at $18.11 (market cap $1.82B). The key difference: Intuitive Surgical, Inc. is far larger — about 80.6× Marqeta Inc's market cap, and Marqeta Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Marqeta Inc for 44 Days on average.
| ISRG | MQ | |
|---|---|---|
Market Cap | $146.76B | $1.82B |
Volume | 2,529,814 | 1,126,466 |
Sector | Health | Technology |
52-Week High | $592.85 | $20.32 |
52-Week Low | $332.02 | $15.04 |
Typical Hold Time | 84 Days | 44 Days |
Enterprise Value | $141.54B | $1.13B |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
MQ trades at $17.44, up 2.23% today, with a bullish technical signal from moving averages. The company reported three consecutive quarterly EPS beats, with Q3 2026 results due November 3. Revenue grew to $625M in 2025, but net income was negative. Analyst consensus is mixed, with 32% buy ratings but a price target of $11.38, below the current price. Recent news includes partnerships with BVNK for stablecoin cards and Google for wallet expansions.
MQ shows operational improvement with positive cash flow in 2025, but high valuation ratios and thin margins pose risks. The stock faces headwinds from contract renewals in Q3 2026, which may slow growth. Upside depends on sustained earnings beats and successful product expansions. Investors should weigh the bullish technicals against fundamental challenges and analyst caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →